XML 55 R37.htm IDEA: XBRL DOCUMENT v3.25.1

Shareholders' Equity (Tables)

12 Months Ended

Dec. 31, 2024

Stockholders' Equity Note [Abstract]

Schedule of assumptions used in estimation of grant date fair value of options

Average Risk-free interest rate (a)			1.79	%
Expected dividend yield			0.0	%
Average expected volatility (b)			44.38	%
Termination rate			9	%
Suboptimal factor (c)			3.16

	(a)	Risk-free interest rate represents risk free US$ zero-coupon US Government Bonds at time of grant.
	(b)	Expected average volatility represents a weighted average standard deviation rate for the price of the Company’s ordinary shares on the NASDAQ National Market.
	(c)	Suboptimal factor represents the multiple of the increase in the market share price on the day of grant of the option which, should it come to pass, will lead to exercise of the option by the employee. It is the average suboptimal factor of the Company and similar companies.

Average Risk-free interest rate (a)			3.01	%
Expected dividend yield			0.0	%
Average expected volatility (b)			43.93	%
Termination rate			9	%
Suboptimal factor (c)			3.14

	(a)	Risk-free interest rate represents risk free US$ zero-coupon US Government Bonds at time of grant.
	(b)	Expected average volatility represents a weighted average standard deviation rate for the price of the Company’s ordinary shares on the NASDAQ National Market.
	(c)	Suboptimal factor represents the multiple of the increase in the market share price on the day of grant of the option which, should it come to pass, will lead to exercise of the option by the employee. It is the average suboptimal factor of the Company and similar companies.

Average Risk-free interest rate (a)			2.91	%
Expected dividend yield			0.0	%
Average expected volatility (b)			44.02	%
Termination rate			9	%
Suboptimal factor (c)			3.14

	(a)	Risk-free interest rate represents risk free US$ zero-coupon US Government Bonds at time of grant.
	(b)	Expected average volatility represents a weighted average standard deviation rate for the price of the Company’s ordinary shares on the NASDAQ National Market.
	(c)	Suboptimal factor represents the multiple of the increase in the market share price on the day of grant of the option which, should it come to pass, will lead to exercise of the option by the employee. It is the average suboptimal factor of the Company and similar companies.

Average Risk-free interest rate (a)			3.91	%
Expected dividend yield			0.0	%
Average expected volatility (b)			41.78	%
Termination rate			7	%
Suboptimal factor (c)			2.76

	(a)	Risk-free interest rate represents risk free US$ zero-coupon US Government Bonds at time of grant.
	(b)	Expected average volatility represents a weighted average standard deviation rate for the price of the Company’s ordinary shares on the NASDAQ National Market.
	(c)	Suboptimal factor represents the multiple of the increase in the market share price on the day of grant of the option which, should it come to pass, will lead to exercise of the option by the employee. It is the average suboptimal factor of the Company and similar companies.

Average Risk-free interest rate (a)			4.22	%
Expected dividend yield			0.0	%
Average expected volatility (b)			42.84	%
Post-vesting termination rate			7	%
Suboptimal factor (c)			2.76

	(a)	Risk-free interest rate represents risk free US$ zero-coupon US Government Bonds at time of grant.
	(b)	Expected average volatility represents a weighted average standard deviation rate for the price of the Company’s ordinary shares on the NASDAQ National Market.
	(c)	Suboptimal factor represents the multiple of the increase in the market share price on the day of grant of the option which, should it come to pass, will lead to exercise of the option by the employee. It is the average suboptimal factor of the Company and similar companies.

Schedule of stock option summary

Options outstanding

Options exercisable

Weighted average

Weighted average

remaining

remaining

Exercise price

Number

contractual life

Number

contractual life

US$

of options

(in years)

of options

(in years)

33.27

10,148

1.3

10,148

1.3

16.42

395,422

7.5

-

-

Schedule of stock option activity

										Weighted
						Weighted				average
		Number				average				grant date
		of options				exercise price				fair value
						US$				US$
Balance at January 1, 2022			579,521
Granted			198,174				40.82				15.13
Exercised			(66,298	)			33.09				13.21
Forfeited			(50,335	)			41.67				15.75
Balance at December 31, 2022			661,062
Granted			137,911				35.12				15.84
Exercised			(45,474	)			29.91				12.33
Forfeited			(14,256	)			40.40				15.90
Expired			(729,095	)			37.80				15.05
Balance at December 31, 2023			10,148
Granted			410,714				16.42				7.08
Forfeited			(15,292	)			16.42				7.08
Balance at December 31, 2024			405,570
Exercisable at December 31, 2024			10,148

Schedule of restricted share units activity

						Weighted
		Number of				average
		Restricted				grant date
		Share Units				fair value
						US$
Balance at January 1, 2022			86,000
Granted			16,000				43.02
Forfeited			(2,000	)			35.33
Vested			(43,000	)			35.33
Balance at December 31, 2022			57,000
Granted			86,000				36.24
Forfeited			(8,000	)			36.24
Vested			(41,000	)			35.33
Balance at December 31, 2023			94,000
Granted			2,969				15.42
Forfeited			(500	)			43.02
Vested			(8,000	)			36.24
Balance at December 31, 2024			88,469

Schedule of allocation of the stock-based compensation expenses

		Year ended December 31
		2022				2023				2024
		US$ thousands
Cost of sales			638				428				276
Research and development costs			1,454				1,423				1,373
Selling and marketing expenses			774				747				728
General and administrative expenses			711				755				789
			3,577				3,353				3,166

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration